Annals of internal medicine

• Latest
• Best
• Search…

• Ann. Intern. Med. · Nov 2020

  Comment

  In type 2 diabetes, GLP-1 RA plus SGLT2 inhibitor vs. either drug alone reduces HbA1c and SBP and may reduce body weight.

  Mantsiou C, Karagiannis T, Kakotrichi P, et al. Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2020;22:1857-68. 32476254.

  expand abstract… mark as read…

• Ann. Intern. Med. · Nov 2020

  Comment

  Antibody tests have higher sensitivity at ≥15 days after symptom onset and 99% specificity for detecting SARS-CoV-2.

  Deeks JJ, Dinnes J, Takwoingi Y, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020;6:CD013652. 32584464.

  keep reading… or not…

• Ann. Intern. Med. · Nov 2020

  Comment

  In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalization.

  Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383:1413-24. 32865377.

  expand abstract… or not…

• Ann. Intern. Med. · Nov 2020

  Comment

  In older adults with type 1 diabetes, continuous glucose monitoring reduced hypoglycemia over 6 months.

  Pratley RE, Kanapka LG, Rickels MR, et al. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. JAMA. 2020;323:2397-406. 32543682.

  read more… or not…

• Ann. Intern. Med. · Nov 2020

  Letter Case Reports

  Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports.

  no abstract available

  read more… mark as read…